Tandem Diabetes Insulin Pump Demand to Surge Despite Popular Demand Of Weight Loss Drugs, Bullish Analyst Says
Humana Star Ratings Plunge Is Latest in Recent Medicare Setbacks
Johnson & Johnson's Options: A Look at What the Big Money Is Thinking
Companies Heavily Investing in AI Have Low Quant Valuation Grades
Gritstone Downgraded by Jones, B. Riley Over Cancer Vaccine Data
Decoding UnitedHealth Group's Options Activity: What's the Big Picture?
Understanding UnitedHealth Group's Position In Health Care Providers & Services Industry Compared To Competitors
Eli Lilly Commits $4.5B To New Facility, Banking On Mounjaro, Zepbound's Weight Loss Success Despite Short-Term Stock Challenges
"Cash is king" is outdated, these assets are more worth buying.
The outlook for cash assets is becoming bleak, and a rate cut by the Federal Reserve will erode the yield of cash assets.
J&J Prostate Cancer Therapy Outperforms in Real-world Study
Bristol-Myers Tops Growth Chart Among S&P 500 Healthcare Stocks in Q3
Humana's Stock Rocked After a Medicare Advantage Plan's Rating Is Set to Drop
Johnson & Johnson Presents Results From Study Showing That ERLEADA Demonstrates Statistically Significant And Clinically Meaningful Improvement In Overall Survival Compared To Enzalutamide In Patients With Metastatic Castration-sensitive Prostate Cancer
Slowdown in medical care recruitment impacts the USA labor market, investors focus on Friday's non-farm data.
The slowdown in recruitment in the medical care industry in the USA poses a threat to the overall stability of the labor market.
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Wednesday as Investors Exercise Caution Amid Mid-East Tensions
Industry Leader Thermo Fisher's Contract Services Positioned For Growth Amid Popular Demand For GLP-1 Weight Loss Drugs, Analyst Initiates With Long-Term Growth Potential
US HHS Reveal Cost Savings For 54 Prescription Drugs Including Novartis' Cancer Drug, Ozempic Could Be Next
CVS, Cigna PBMs Targeted as Lawmakers Criticize New "Anti-competitive" Move
The Covid Era Tech Promises To Reinvent Cancer Treatment
Johnson & Johnson To Invest More Than $2B In New, Advanced Technology Manufacturing Facility In North Carolina To Support Robust Portfolio Growth